Medtronic
Open enrollment across a mixed-phase pipeline
According to ClinicalTrials.gov-derived indexes, Medtronic sits in the top decile of US sponsors by registered trial count (#538 of 15,742 sponsors by registered trial count).
Medtronic: 30 sponsored US clinical trials, 3 recruiting.
Medtronic sponsors 30 registered US clinical trials on ClinicalTrials.gov, 3 of them currently recruiting, and 19 completed. The most-studied condition in this pipeline is Bradycardia, with 6 trials.
Top-decile sponsor footprint
Medtronic ranks in the top decile of sponsors by registered trial count (#538 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
19 of 19 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (100.0%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
30 total, page 1 of 1
Post Market Evaluation of Real World Outcomes and Durability to Support Implantable Inceptiv™ Spinal Cord Stimulation Therapy
NCT07507422
Product Surveillance Registry
NCT01524276
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
NCT00271180
Enlighten Study: The EV-ICD Post Approval Registry
NCT06048731
IN.PACT™ AV Access Post-Approval Study (PAS002)
NCT04543539
Personalized Therapy Study - Intrinsic Antitachycardia Pacing Post-Approval Study (iATP PAS)
NCT04496518
Personalized Therapy Study - HFRS (TriageHF) Post Approval Study
NCT04489225
Longitudinal Coverage With Evidence Development Study on Micra AV Leadless Pacemakers (Micra AV CED)
NCT04235491
Personalized Therapy Study - Attain Stability Quad Post-Approval Study
NCT04024943
Longitudinal Coverage With Evidence Development Study on Micra Leadless Pacemakers
NCT03039712
Micra Transcatheter Pacing System Post-Approval Registry
NCT02536118
Medtronic Signia SDR Product Surveillance Registry
NCT05095935
Micra AV Transcatheter Pacing System Post-Approval Registry
NCT04253184
Personalized CRT - MPP Post Approval Study
NCT03232944
3T MRI CIED Post-Approval Study
NCT02969395
Micra Transcatheter Pacing System Continued Access Study Protocol
NCT02488681
Attain Performa™ Left Ventricular (LV) Quadripolar Leads Chronic Performance Study
NCT02294331
The Product Surveillance Registry REVERSE Post Approval Study
NCT01660035
Personalized CRT - PSR
NCT03723265
DF4 Connector System Post-Approval Study
NCT01638897
Model 4396 Left Ventricular (LV) Lead Chronic Performance Study
NCT01361685
Model 4296 Left Ventricular (LV) Lead Chronic Performance Study
NCT01361672
SureScan Post-Approval Study
NCT01299675
Model 4196 Left Ventricular (LV) Lead Chronic Performance Study
NCT00930904
Model 4195 Left Ventricular (LV) Lead Chronic Performance Study
NCT00869921
MEDTRONIC ADAPTA, VERSA AND SENSIA nEw3 POST APPROVAL STUDY
NCT01076374
Platelets for Acute Wound Healing
NCT00125086
Platelets in Acute Wounds: A Pilot Study (PAWS)
NCT00199992
Model 4968 CAPTURE EPI® STERIOD-ELUTING BIPOLAR EPICARDIAL PACING LEAD Post-approval Study
NCT01076361
Model 4965 Post-Approval Study
NCT01076348
Therapeutic Areas
What is open in the Medtronic pipeline
3 recruiting of 30 indexed (10% open); 19 completed (63%).
Phase labels are sparse on this sponsor index, so phase mix is not charted here.
Top condition: Bradycardia (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Medtronic: open-pipeline peers nationwide
Peers matched on 30 registered trials and 10% open enrollment, not the therapeutic-area sidebar.
Medtronic sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 30 trials (± recruiting share)
- Biotronik · 30 trials · 3% recruiting
- Charles Drew University of Medicine and Science · 30 trials · 3% recruiting
- Chiesi Farmaceutici S.p.A. · 30 trials · 13% recruiting
- Debiopharm International · 30 trials · 17% recruiting
Sponsors near 10% open enrollment (± trial volume)
- Abiomed · 10% recruiting · 20 trials
- Aimmune Therapeutics · 10% recruiting · 10 trials
- Altria Client Services · 10% recruiting · 10 trials
- Alzheimer's Disease Cooperative Study (ADCS) · 10% recruiting · 10 trials
Related
What to do with this Medtronic page
30 registered trials is a research-attention snapshot, not an endorsement of Medtronic or any single study.
- 3 of Medtronic's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Bradycardia is the condition Medtronic studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Bradycardia trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Medtronic pipeline card: 30 registered trials from official public datasets.Report a data error.